Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

BUY
$98.9 - $132.37 $1.75 Million - $2.34 Million
17,700 Added 118.0%
32,700 $4.15 Million
Q4 2021

Feb 15, 2022

BUY
$110.64 - $159.4 $1.11 Million - $1.59 Million
10,000 Added 200.0%
15,000 $1.97 Million
Q1 2021

May 18, 2021

SELL
$95.46 - $133.08 $391,386 - $545,628
-4,100 Reduced 45.05%
5,000 $601,000
Q4 2020

Feb 17, 2021

BUY
$75.23 - $109.23 $300,920 - $436,920
4,000 Added 78.43%
9,100 $924,000
Q3 2020

Nov 17, 2020

BUY
$71.31 - $109.74 $149,751 - $230,454
2,100 Added 70.0%
5,100 $394,000
Q2 2020

Aug 17, 2020

BUY
$62.14 - $117.21 $186,420 - $351,630
3,000 New
3,000 $334,000

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.